Skip to main content
Skip to content
Case File
efta-01519491DOJ Data Set 10Other

EFTA01519491

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01519491
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL - OAP ifID ACCT. For die Period 3/1/14 to 3/31/14 Equity Summary Asset Categories Beginning Ending Change Current Market Value Market Value In Value Allocation EAFE Equity 137,528.10 0.00 (137,528.10) Equity Detail Pnce Quantity Value Adjusted Tax Cost Unrealized Gain/Loss Est. Annual Inc. Yield Original Cost Accrued Div. EA FE Equity GLAXOSMITHKLINE PLC 53.43 0.00 4.62% SPONS ADR 684.77 37733W-10-5 GSK KIRIN HOLDINGS COMPANY LTD 13.85 0.00 2.00% SPONS ADR 476.23 497350-30-6 KNBW FtECKITT BENCKISER GROUP PLC 16.48 0.00 2.57% SPONSORED ADR 776.95 756255-20-4 RBGL Total WE Equity $0.00 S0.00 $0.00 $0.00 0.00% $1.937.95 JP Morgan Page 3 of 7 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00046778 SDNY_GM_00315976 EFTA01519491

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.